cardiovascular disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients were Asian. From September 2004 to September 2015, patients participated in CR during hospitalization for percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), valvular surgery, congestive heart failure (CHF), aortic aneurysm, and dissecting aneurysm of the aorta (DA) at Sakakibara Heart Institute (Tokyo, Japan).
Exclusion criteria
Exclusion criteria: The patients whose CR program was not completed for death or severe events including acute coronary syndrome and cerebral infarction within 150 days or could not continue program over 90 days for any other reasons including busy daily schedule were excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The endpoint of this study is all death and major adverse cardiovascular events (MACE: composed of cardiac death, acute coronary syndrome, cerebral infarction, acute aortic syndrome, and hospitalization for heart failure) > 150 days after starting CR program. We performed separate analyses according to a landmark (cutoff) point of 150 days after starting CR program, therfore, the CR participants with events occurring < 150 days after starting CR program were excluded from this study to minimize the bias in comparing the outcomes of all groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| surgery for abdominal aortic aneurysm Arrhythmia | — |
Countries
Japan
Contacts
Cardiac rehabilitation Department of cardiology